CS200550B2 - Method of producing dextrorotatory isomers of asymetric spiro-hydantoin compounds - Google Patents

Method of producing dextrorotatory isomers of asymetric spiro-hydantoin compounds Download PDF

Info

Publication number
CS200550B2
CS200550B2 CS783021A CS302178A CS200550B2 CS 200550 B2 CS200550 B2 CS 200550B2 CS 783021 A CS783021 A CS 783021A CS 302178 A CS302178 A CS 302178A CS 200550 B2 CS200550 B2 CS 200550B2
Authority
CS
Czechoslovakia
Prior art keywords
spiro
fluoro
dione
optically active
compounds
Prior art date
Application number
CS783021A
Other languages
Czech (cs)
English (en)
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS200550B2 publication Critical patent/CS200550B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CS783021A 1977-05-23 1978-05-11 Method of producing dextrorotatory isomers of asymetric spiro-hydantoin compounds CS200550B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/799,586 US4130714A (en) 1977-05-23 1977-05-23 Hydantoin therapeutic agents

Publications (1)

Publication Number Publication Date
CS200550B2 true CS200550B2 (en) 1980-09-15

Family

ID=25176274

Family Applications (1)

Application Number Title Priority Date Filing Date
CS783021A CS200550B2 (en) 1977-05-23 1978-05-11 Method of producing dextrorotatory isomers of asymetric spiro-hydantoin compounds

Country Status (37)

Country Link
US (1) US4130714A (fr)
JP (1) JPS6035350B2 (fr)
AR (1) AR219531A1 (fr)
AT (1) AT357170B (fr)
AU (1) AU499518B1 (fr)
BE (1) BE867248A (fr)
CA (1) CA1088073A (fr)
CH (1) CH631455A5 (fr)
CS (1) CS200550B2 (fr)
DD (1) DD137107A5 (fr)
DE (2) DE2821966C2 (fr)
DK (1) DK147941C (fr)
EG (1) EG13691A (fr)
ES (1) ES470070A1 (fr)
FI (1) FI62838C (fr)
FR (1) FR2392024A1 (fr)
GB (1) GB1572688A (fr)
GR (1) GR68694B (fr)
HK (1) HK53981A (fr)
HU (1) HU177718B (fr)
IE (1) IE47273B1 (fr)
IL (1) IL54754A (fr)
IN (1) IN147854B (fr)
IT (1) IT1096306B (fr)
KE (1) KE3168A (fr)
LU (1) LU79685A1 (fr)
MY (1) MY8200156A (fr)
NL (1) NL7804158A (fr)
NO (1) NO150206C (fr)
NZ (1) NZ187334A (fr)
PH (1) PH13828A (fr)
PL (1) PL110460B1 (fr)
PT (1) PT68071B (fr)
SE (1) SE437375B (fr)
SU (1) SU873885A3 (fr)
YU (1) YU40829B (fr)
ZA (1) ZA782919B (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (fr) * 1976-10-18 1980-11-04 Pfizer Limited Derives de l'hydantoine utilises comme agents therapeutiques
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4419521A (en) * 1981-11-12 1983-12-06 Pfizer Inc. 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4528387A (en) * 1982-11-10 1985-07-09 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4431828A (en) * 1982-11-10 1984-02-14 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US5153211A (en) * 1983-09-14 1992-10-06 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
EP0159143B1 (fr) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-indènes et spiro-dihydro-1,2-naphtalènes pour le traitement de complications diabétiques
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 ３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
US4680306A (en) * 1984-07-20 1987-07-14 Pfizer Inc. Sprio-imidazolones for treatment of diabetes complications
US4656169A (en) * 1984-08-14 1987-04-07 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4620019A (en) * 1984-08-23 1986-10-28 Pfizer Inc. S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
WO1986007353A1 (fr) 1985-06-14 1986-12-18 Pfizer Inc. Produit intermediaire utilise dans la producton d'hydantoines asymetriques
JPS627654U (fr) * 1985-06-26 1987-01-17
HU206618B (en) * 1986-01-17 1992-12-28 Pfizer Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
WO1992000071A1 (fr) * 1989-02-10 1992-01-09 Washington Research Foundation Agents immunoregulateurs
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5236945A (en) * 1990-06-11 1993-08-17 Pfizer Inc. 1H-indazole-3-acetic acids as aldose reductase inhibitors
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
KR950703539A (ko) * 1992-09-28 1995-09-20 알렌 제이. 스피겔 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications)
US5521208A (en) * 1993-07-29 1996-05-28 Alcon Laboratories, Inc. Compositions and methods for the treatment of the metabolically impaired and for improved compliance
HUP0000838A3 (en) * 1997-04-15 2001-04-28 Csir Extract containing steroid-glucosid, process for its isolation and synthesis, pharmaceutical composition containing it having appetite suppressant activity
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
PL365378A1 (en) 2000-11-30 2005-01-10 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US8877717B2 (en) 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos
US8273746B2 (en) * 2007-03-23 2012-09-25 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
EP2654749B1 (fr) 2010-12-23 2017-05-10 The Board of Regents of The University of Texas System Méthodes de traitement de copd
UA118035C2 (uk) * 2013-10-07 2018-11-12 Сінгента Партісіпейшнс Аг Гербіцидні сполуки
WO2019165195A1 (fr) 2018-02-22 2019-08-29 Srivastava Satish Polythérapie destinée au traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (fr) * 1976-10-18 1980-11-04 Pfizer Limited Derives de l'hydantoine utilises comme agents therapeutiques

Also Published As

Publication number Publication date
AR219531A1 (es) 1980-08-29
FI62838C (fi) 1983-03-10
HU177718B (en) 1981-12-28
IE47273B1 (en) 1984-02-08
FR2392024B1 (fr) 1981-07-24
IT7823672A0 (it) 1978-05-22
PL206826A1 (pl) 1979-04-23
IN147854B (fr) 1980-07-19
IL54754A0 (en) 1978-07-31
NZ187334A (en) 1984-04-27
DD137107A5 (de) 1979-08-15
LU79685A1 (fr) 1979-12-06
GR68694B (fr) 1982-02-01
JPS6035350B2 (ja) 1985-08-14
DK226778A (da) 1978-11-24
SU873885A3 (ru) 1981-10-15
ZA782919B (en) 1979-06-27
ATA365378A (de) 1979-11-15
EG13691A (en) 1982-12-31
GB1572688A (en) 1980-07-30
PT68071A (en) 1978-06-01
KE3168A (en) 1981-11-06
DE2858042C2 (de) 1983-11-24
CA1088073A (fr) 1980-10-21
IL54754A (en) 1982-04-30
NO150206B (no) 1984-05-28
IT1096306B (it) 1985-08-26
ES470070A1 (es) 1979-01-01
MY8200156A (en) 1982-12-31
US4130714A (en) 1978-12-19
FI62838B (fi) 1982-11-30
AT357170B (de) 1980-06-25
DE2821966A1 (de) 1978-11-30
IE781015L (en) 1978-11-23
JPS53144575A (en) 1978-12-15
SE7803626L (sv) 1978-11-24
BE867248A (fr) 1978-11-20
YU40829B (en) 1986-06-30
FR2392024A1 (fr) 1978-12-22
DK147941B (da) 1985-01-14
FI781613A (fi) 1978-11-24
HK53981A (en) 1981-11-13
DK147941C (da) 1985-08-26
SE437375B (sv) 1985-02-25
PL110460B1 (en) 1980-07-31
YU116978A (en) 1983-02-28
NL7804158A (nl) 1978-11-27
DE2821966C2 (de) 1983-06-01
NO781769L (no) 1978-11-24
AU499518B1 (en) 1979-04-26
CH631455A5 (fr) 1982-08-13
PT68071B (en) 1979-10-26
PH13828A (en) 1980-10-07
NO150206C (no) 1984-09-05

Similar Documents

Publication Publication Date Title
CS200550B2 (en) Method of producing dextrorotatory isomers of asymetric spiro-hydantoin compounds
CS199690B2 (cs) Způsob výroby spiro-hydantoinových derivátů
FI65255C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro(4h-2,3-dihydrobenzopyran(4,5')oxazolidin)-2',4'-dioner
EP0017379B1 (fr) Dérivés de spiro-imidazolidinedione phényl- ou phénoxy-substitués, leurs compositions pharmaceutiques et procédé pour leur préparation
DE2759927C2 (de) Spiro-hydantoin-Verbindungen
US4147795A (en) Hydantoin derivatives as therapeutic agents
DE69018876T2 (de) Pyridazinon-Derivate.
FR2543140A1 (fr) Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
US4406908A (en) Tetrazolylcoumarin derivatives and antiallergic compositions containing the same
JPH0536436B2 (fr)
US4209527A (en) Benzimidazolone derivatives
US4177282A (en) Hydantoin therapeutic agents
JPH05390B2 (fr)
US3954981A (en) Triazolocycloalkylhydrothiadiazine derivatives
US3944524A (en) 4-Substituted-1-piperidinesulfonamides
FI77235B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara spiro-polycykliska imidazolidindionderivat.
FI63579B (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar spiro-benso(b)tiofen(3,4')imidazolidin-2,5-dion-1,1-dioxid
KR820001306B1 (ko) 스피로-히단토인 화합물의 제조방법
KR820000097B1 (ko) 피리도[2,1-b] 퀴나졸린 유도체의 제조방법
KR830000329B1 (ko) 스피로-옥사졸리딘디온의 제조방법
KR830001244B1 (ko) 스피로-폴리사이클릭 이미다졸리딘 디온 유도체의 제조방법
WO1999051577A1 (fr) Derives d'acide propionique (s)-2-(biphenyle-4-sulfonylamino)-3-(1h-indolyle) utilises comme inhibiteurs de metalloprotease matricielle
FR2511683A1 (fr) Nouveaux derives de la pyrido (2,3-b) benzothiazepine(1,5) substituee en 5 par une carboxypiperazine, leur procede de preparation, leur application en therapeutique
NZ194846A (en) Hydrobenzopyrans (or furans)or thio functions and their preparations